<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02429609</url>
  </required_header>
  <id_info>
    <org_study_id>ANDO1009</org_study_id>
    <nct_id>NCT02429609</nct_id>
  </id_info>
  <brief_title>Exploring the Psychophysics of Keratoconus Using the Moorfields Acuity Chart</brief_title>
  <acronym>MACK</acronym>
  <official_title>Exploring the Psychophysics of Keratoconus Using the Moorfields Acuity Chart</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moorfields Eye Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moorfields Eye Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The measurement of visual acuity is made using black letters of varying size superimposed on&#xD;
      a uniform white background. The objective is to determine the smallest letter, or optotype,&#xD;
      that can be correctly identified. One limitation of current tests is the variability of&#xD;
      measurements, this making it difficult for clinicians to determine if changes in visual&#xD;
      acuity are related to ocular disease. This variability has been attributed to the design of&#xD;
      current optotypes, in particular their differing legibilities. Our group has recently&#xD;
      demonstrated that a new type of letter chart (Moorfields Acuity Chart), containing letters&#xD;
      with a black core and a white border presented on a grey background, reduces the variability&#xD;
      of visual acuity measurements. In this study the investigators wish to determine if changes&#xD;
      in vision owing to keratoconus, a disease that causes the cornea to adopt an irregular shape,&#xD;
      may be detected more easily using the Moorfields Acuity Chart compared with conventional&#xD;
      letter charts.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The relative difference in visual acuity measurement between subjects with and without keratoconus when examined with different types of visual acuity chart.</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relationship (if any) between optical imperfections (high order aberrations) and measurements of visual acuity when measured using different test chart designs.</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Keratoconic Subjects</condition>
  <arm_group>
    <arm_group_label>Keratoconic subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Short clinical interview (Questions pertaining to ocular and systemic health, medications, family history and date of birth). (approx. 2 minutes)&#xD;
Visual acuity measurement using EDTRS chart at 4 m (approx. 4 minutes)&#xD;
Refraction: retinoscopy and subjective, at 4m (approx. 10 minutes)&#xD;
Anterior eye examination (approx. 4 minutes)&#xD;
Fundus examination using binocular indirect ophthalmoscopy or a standard ophthalmoscope - to screen for eye disease that is likely to affect visual ability in this study. (approx. 5 minutes)&#xD;
Corneal topography measurement with an Oculus Pentacam (Oculus Gmbh., Germany). (approx. 5 minutes)&#xD;
Two measurements of visual acuity will be made:&#xD;
Standard ETDRS logMAR acuity measurement (5 minutes)&#xD;
Vanishing Optotype logMAR acuity measurement (5 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Short clinical interview (Questions pertaining to ocular and systemic health, medications, family history and date of birth). (approx. 2 minutes)&#xD;
Visual acuity measurement using EDTRS chart at 4 m (approx. 4 minutes)&#xD;
Refraction: retinoscopy and subjective, at 4m (approx. 10 minutes)&#xD;
Anterior eye examination (approx. 4 minutes)&#xD;
Fundus examination using binocular indirect ophthalmoscopy or a standard ophthalmoscope - to screen for eye disease that is likely to affect visual ability in this study. (approx. 5 minutes)&#xD;
Corneal topography measurement with an Oculus Pentacam (Oculus Gmbh., Germany). (approx. 5 minutes)&#xD;
Two measurements of visual acuity will be made:&#xD;
Standard ETDRS logMAR acuity measurement (5 minutes)&#xD;
Vanishing Optotype logMAR acuity measurement (5 minutes)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moorfields Acuity Chart</intervention_name>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>Keratoconic subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Keratoconic subjects (50):&#xD;
&#xD;
          -  Age 18-40 years.&#xD;
&#xD;
          -  The presence of keratoconus in at least one eye.&#xD;
&#xD;
          -  The absence of significant media opacities (e.g. cataract, corneal scarring).&#xD;
&#xD;
          -  The absence of any other ocular pathology (e.g. glaucoma, diabetic retinopathy,&#xD;
             uveitis).&#xD;
&#xD;
          -  The absence of amblyopia in the test eye.&#xD;
&#xD;
          -  No previous ocular surgery (e.g. corneal crosslinking, cataract surgery, etc.)&#xD;
&#xD;
          -  Best corrected visual acuity better than or equal to 6/60 (1.0 logMAR).&#xD;
&#xD;
          -  Pupil diameter ≥3 mm and ≤7 mm in normal room illumination.&#xD;
&#xD;
        Healthy subjects (30):&#xD;
&#xD;
          -  Age 18-35 years.&#xD;
&#xD;
          -  The absence of clinically significant keratoconus.&#xD;
&#xD;
          -  The absence of significant media opacities. (e.g. cataract, corneal scarring).&#xD;
&#xD;
          -  The absence of any other ocular pathology (e.g. glaucoma, diabetic retinopathy,&#xD;
             uveitis).&#xD;
&#xD;
          -  The absence of amblyopia in the test eye.&#xD;
&#xD;
          -  No previous ocular surgery (e.g. corneal crosslinking, cataract surgery, etc.)&#xD;
&#xD;
          -  Best corrected visual acuity better than or equal to 6/9 (0.1 logMAR).&#xD;
&#xD;
          -  Pupil diameter ≥3 mm and ≤7 mm in normal room illumination.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Padraig Mulholland, PhD</last_name>
    <email>Padraig.Mulholland@moorfields.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Jones, MSc</last_name>
    <email>res-admin@moorfields.nhs.uk</email>
  </overall_contact_backup>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>April 9, 2015</study_first_submitted>
  <study_first_submitted_qc>April 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2015</study_first_posted>
  <last_update_submitted>April 24, 2015</last_update_submitted>
  <last_update_submitted_qc>April 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

